BPC-157: nitric oxide, angiogenesis, tendon-fibroblast outgrowth BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide first characterized by the Sikiric group at the University of Zagreb beginning in the early 1990s
Heres the simple, no-nonsense version: Initial results: 46 sessions Visible glow: Week 3 onward Peak brightness: Around 2 months Duration of results: 36 months Maintenance: Once every 46 weeks Glutathione works beautifully, but its a treatment , not a permanent switch
A peptide is a short chain of amino acids
In chronic retinal diseases, maintaining M2 phenotype protects neurons from immune-mediated injury
Most peptides investigated in regenerative biology operate within one or two tissue systems
Second, when two sources differ by that much, at least one of them is not describing what it claims to describe